Summary: It has been previously reported that infection by a bovine enterovirus (MZ-468), which does not infect normal human cells, was remarkably effective for the therapy of adult T cell leukemia (ATL) in experimental rabbit models . Therapeutic treatment studies were performed twice on 30 and 20 autochthonous rat ovarian carcinomas induced by DMBA. The average tumor size of the virus treatment group was significantly smaller than the control group when analyzed by a nonparametric Mann-Whitney method (p<0.06 and 0.002 for the 1st and 2nd experiments, respectively). These results indicate that an enterovirus infection may be clinically useful for the therapy of human ovarian cancers with bad prognoses.
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Materials and Methods

Virus
A bovine enterovirus, MZ-468, was isolated in HeLa cells from feces (Shingu, 1991) and the infectivity was assayed using plaque forming methods in MDBK cells. Because MZ-468 is not infectious to normal human tissues, it can be safely manipulated.
Rat
Wister female rats (140-180 g) were subjected
to carcinogenic experiments and were fed with regular food.
Chemical carcino genesis
Surgical strings, each containing 10 p g of 12 dimethylbenz (a)anthracene (DMBA), were clipped into the left ovaries, as previously reported (Kato et al. 1974) , of thirty and twenty rats for the first and second experiments, respectively. Assessment of tumor growth and effects of virus treatment
At the 210th day in the first experiment, laparotomies were carried out and it was found that all the rats bore ovarian tumors.
The dimensions of the tumors were measured and the approximate tumor sizes were calculated as follows (Sawada et al. 1981) . The left ovaries of 30 or 20 rats were clipped with surgical strings containing 10 pg of 7,12-dimethylbenz (a) anthracene (DMBA). At 210 or 190 days after the clipping, a laparotomy was performed in each animal, the tumor size was measured, and an intratumor injection of bovine enterovirus (MZ-468) or MEM was performed. Three days later, an additional intra-peritoneal injection of the virus or MEM was made. Ten or twenty days later, each rat was autopsied and the tumor size was re-measured. and 14 from the control group were autopsied (three rats died from accidents or surgical injuries). The tumor sizes were calculated using equation (1) and a ratio of tumor sizes was calculated as the value of post-treatment size over pre-treatment size. The rat ovaries were subjected to carcinogenic treatment and a laparotomy was performed at the 210th day when the ovaries were treated with an enterovirus, MZ-468 or a control solution, as described in the methods. At the 224th day, each rat was autopsied and typical ovaries from the non-treatment (A) and virus-treatment (B) groups are shown.
MEM, as shown in Fig. 1 . Twenty days later, each group of 9 rats was aut r
Results
All the rats treated with a carcinogenic agent bore ovarian tumors, as described above. A typical ovarian tumor from one rat when a laparotomy was performed on the 210th day is shown in Fig. 2A in Fig. 3 . The significant differences were statistically confirmed by a non-parametric Mann-Whitney method (remarkably large RTS values were obtained in the control group). The results demonstrate that the tumor sizes in the treatment groups were significantly reduced as compared to those in the control groups (p<0.00 and p<0.002 for the 1st and 2nd experiment, respectively). Sizes of ovarian tumors before and after treatment with the enterovirus, MZ-468. The ovarian tumors were induced as described in the methods and the sizes were measured before and after treatment with the virus.
it is difficult to diagnose at an early stage, and various types of tumors occur from multi-potential tissue. Current treatments of the tumors include combination therapies using surgery and anticancer agents, depending on the developmental stages (Rose et al. 1986 ). Severe side effects on the haematopoietic, gastroenteric and other organs are induced by the cytotoxic effects of the anticancer agents on normal cells, which would be eliminated in an ideal therapy. A biological therapy using this virus is one of the ideal therapies because the virus infection is species-specific and has milder side effects. MZ-468 was tested for propagation in several malignant cell types (Shingu, 1981; Shingu et al. 1991) and the inhibition of their colony formations in soft agar, and it was found that adenocarcinomas were more susceptible than squamous cell carcinomas. This property may be advantageous for the treatment of ovarian carcinomas because the adenocarcinomas frequently found in human ovarian carcinomas have a poor prognosis (Rose et al. 1986 ). Furthermore a bovine enterovirus specifically infects malignant cells but does not infect normal cells, which reduces the side effects of the cancer therapy. Thus the oncolytic mechanism of this virus is considered to be a direct cytopathogenic effect, rather than a cell killing effect, by immuno-mediated cells which are secondarily induced by the viral infection. Effective results were obtained on a good experimental model using a clipping method which was able to generate carcinomas in 100% of the ovaries. Using this model, combination therapies involving surgical resection with virus infection or anti-cancer drugs can easily be simulated for the assess-ment of clinical treatment.
